Post-earnings recap
Reported
Wed, Aug 8, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Collegium Pharmaceutical reported a narrower-than-expected loss per share, which led to a positive stock reaction, with shares rising 1.49%. However, there was no revenue reported or guidance provided, leaving some uncertainty about future performance. Investors may view the EPS beat as a sign of improved efficiency or cost management.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.40 | N/A | +2.19% |
| Revenue | N/A | N/A | N/A |
No transcript is on record for this earnings call, so the analysis is based solely on numerical results.